These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 6457206)

  • 41. [Action of antiviral substances on influenza viruses through the inhibition of neuraminidase production].
    Mentel R; Panzig B; Seidel W; Döhner L
    Arch Exp Veterinarmed; 1985 May; 39(3):371-4. PubMed ID: 4051653
    [No Abstract]   [Full Text] [Related]  

  • 42. [The efficacy of Polirem in the prevention of influenza in servicemen].
    Efimov EI; Razgulin SA
    Voen Med Zh; 1995 Feb; (2):48-9, 80. PubMed ID: 8592859
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Prevention of influenza A. Effectiveness and tolerance of rimantadine hydrochloride].
    Bricaire F; Hannoun C; Boissel JP
    Presse Med; 1990 Jan; 19(2):69-72. PubMed ID: 2137233
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Genetic basis of resistance to rimantadine emerging during treatment of influenza virus infection.
    Belshe RB; Smith MH; Hall CB; Betts R; Hay AJ
    J Virol; 1988 May; 62(5):1508-12. PubMed ID: 3282079
    [TBL] [Abstract][Full Text] [Related]  

  • 45. I wish to comment on several points in the recent "Guidelines".
    Drew WL
    J Clin Virol; 2005 May; 33(1):79. PubMed ID: 15797370
    [No Abstract]   [Full Text] [Related]  

  • 46. [Effect of amantadine (1-aminoadamantane) and remantadine (alpha-methyl-1-adamantane methyl amine) hydrochlorides on formation of influenza A viral proteins].
    Galegov GA; Vladyko AS; Linitskaia GL; Shobukhov VM
    Vopr Med Khim; 1981; 27(2):251-4. PubMed ID: 7281566
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Rimantadine approved for treatment, prophylaxis of influenza A.
    Am J Hosp Pharm; 1994 Jan; 51(1):16. PubMed ID: 8135257
    [No Abstract]   [Full Text] [Related]  

  • 48. Antiviral therapy and prophylaxis for influenza in children.
    American Academy of Pediatrics Committee on Infectious Diseases
    Pediatrics; 2007 Apr; 119(4):852-60. PubMed ID: 17403862
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Uncoating of a rimantadine-resistant variant of influenza virus in the presence of rimantadine.
    Bukrinskaya AG; Vorkunova NK; Pushkarskaya NL
    J Gen Virol; 1982 May; 60(Pt 1):61-6. PubMed ID: 7097251
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Effect of remantadine on the development of toxicoses caused by different strains of influenza virus].
    Kiseleva IV
    Vopr Virusol; 1981; (5):541-3. PubMed ID: 7336681
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Using antiviral agents to control outbreaks of influenza A infection.
    Monto AS
    Geriatrics; 1994 Dec; 49(12):30-4. PubMed ID: 7982583
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Study of the sensitivity of different strians of the influenza A2 virus of rimantadine].
    Pushkarskaia NL; Obrosova-Serova NP; Shenderovich SF; Zaketel'skaia LIa; Galegov GA
    Vopr Virusol; 1977; (4):421-4. PubMed ID: 919499
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Combined action of antiviral substances of natural and synthetic origin. I. The anti-influenza action of a combination of the polyphenol complex isolated from Geranium sanguineum L. and remantadine in vitro and in ovo].
    Serkedzhieva Iu; Manolova N; Maksimova-Todorova V; Gegova G
    Acta Microbiol Bulg; 1986; 19():18-22. PubMed ID: 3565089
    [No Abstract]   [Full Text] [Related]  

  • 54. Evidence for cytokine mediation of disease expression in adults experimentally infected with influenza A virus.
    Skoner DP; Gentile DA; Patel A; Doyle WJ
    J Infect Dis; 1999 Jul; 180(1):10-4. PubMed ID: 10353855
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Organization and evaluation of the effectiveness of emergency prophylaxis and early treatment of influenza with remantadine in Serevodvinsk].
    Gagarinova VM; Shadrin AS; Kubar' OI; Kustikova IuG; Araslanova II
    Zh Mikrobiol Epidemiol Immunobiol; 1983 Mar; (3):60-3. PubMed ID: 6221493
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Sensitivity to remantadine and ribavirin of influenza A virus resistant to 2-(1'-aminoethyl)-bicyclo(2.2.1)heptane hydrochloride].
    Gribkova NV; Kazak NF; Votiakov VI
    Vopr Virusol; 1984; 29(5):619-21. PubMed ID: 6516328
    [No Abstract]   [Full Text] [Related]  

  • 57. [Remantadine prophylaxis of influenza in an industrial enterprise].
    Smirnov VV; Grigor'ev AV
    Vopr Virusol; 1982; 27(3):375-7. PubMed ID: 7123918
    [No Abstract]   [Full Text] [Related]  

  • 58. [Rimantadine and arbidol sensitivity of influenza viruses that caused epidemic morbidity rise in Russia in the 2004-2005 season].
    Burtseva EI; Shevchenko ES; Leneva IA; Merkulova LN; Oskerko TA; Shliapnikova OV; Zaplatnikov AL; Shuster AM; Slepushkin AN
    Vopr Virusol; 2007; 52(2):24-9. PubMed ID: 17500235
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Interaction of rimantadine with the lipid membrane of influenza virus variants sensitive to the drug].
    Kharitonenkov IG; Ginzburg VP; Klimov AI; Tikhonov AN
    Vopr Virusol; 1982; 27(5):52-4. PubMed ID: 7147902
    [No Abstract]   [Full Text] [Related]  

  • 60. Characterization of the effect of rimantadine on intracellular distribution and transport into the nuclei of infected cells of the parent influenza virus genome.
    Kozeletskaya KN; Yukhnova LG; Golubev DB
    Acta Virol; 1984 Nov; 28(6):464-72. PubMed ID: 6152124
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.